SpineGuard SA (EPA:ALSGD)
France
· Delayed Price · Currency is EUR 0.1028
+0.0004 (0.39%)
Jun 27, 2025, 2:34 PM CET
SpineGuard Revenue
In the year 2024, SpineGuard had annual revenue of 4.65M EUR with 7.77% growth. SpineGuard had revenue of 2.20M in the half year ending December 31, 2024, a decrease of -27.88%.
Revenue
4.65M
Revenue Growth
+7.77%
P/S Ratio
1.39
Revenue / Employee
211.27K
Employees
22
Market Cap
6.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.65M | 335.24K | 7.77% |
| Dec 31, 2023 | 4.31M | -1.29M | -22.98% |
| Dec 31, 2022 | 5.60M | 1.19M | 27.11% |
| Dec 31, 2021 | 4.41M | -446.53K | -9.20% |
| Dec 31, 2020 | 4.85M | -1.98M | -28.95% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 26.51B |
| Sanofi | 45.17B |
| Sartorius Stedim Biotech | 2.86B |
| bioMérieux | 3.98B |
| Eurofins Scientific SE | 6.95B |
| Ipsen | 3.57B |
| Virbac | 1.40B |
| Clariane SE | 5.28B |